• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Children’s National Hospital Awarded $8M to Advance AlgometRx Nociometer

by Jasmine Pennic 10/23/2024 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
Children's National Hospital Awarded $8M to Advance AlgometRx Nociometer

What You Should Know: 

– Children’s National Hospital has received a $8M award from the Advanced Research Projects Agency for Health (ARPA-H) to further develop the AlgometRx Nociometer, a device designed to objectively measure pain. 

– Led by Dr. Julia Finkel, a pediatric anesthesiologist at Children’s National, aims to transform pain management and address the unmet needs of patients, particularly women, who often experience disparities in pain assessment and treatment.

Addressing the Challenges of Pain Assessment

Traditional pain assessment methods often rely on subjective measures, such as visual rating scales with faces depicting different levels of pain. These methods can be imprecise and fail to capture the complex nature of pain, leading to inadequate treatment and frustration for both patients and clinicians.

The AlgometRx Nociometer: A New Era of Pain Measurement

The Nociometer offers a more objective and precise approach to pain assessment. This portable device utilizes non-invasive technology and algorithms to analyze pupil dilation and the body’s response to stimulation along specific nerves. In under a minute, the device can generate a patient profile that quantifies how the nervous system processes pain signals.

Addressing Gender Disparities in Pain

This project is part of the ARPA-H Sprint for Women’s Health, an initiative focused on addressing unmet challenges in women’s health. Dr. Finkel’s research aims to improve the understanding of gender differences in pain and develop more effective treatments for women.

“As physicians, we often feel helpless to understand how our patients are experiencing pain and whether treatments are working,” Dr. Finkel said. “We use the Visual Analog Scale, which fails to classify the pain’s etiology or help guide a specific intervention, often leaving us to treat by trial and error. The Nociometer will change that.” 

“Research studies have long shown that pain in women and girls is underestimated and undertreated,” Dr. Finkel said. “Creating a novel technology to quantify pain has tremendous applications in pinpointing and effectively treating pain, potentially altering treatment in nearly any medical setting.” 

Collaboration and Support

Children’s National will collaborate with researchers from Johns Hopkins University and Medstar Research Institute on this project. The $8M award will be distributed over two years through ARPA-H’s launchpad track, which provides funding and support for later-stage health solutions.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |